Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eurofins Amatsigroup is a Eurofins CDMO business focused on outsourced drug development and manufacturing services for biopharmaceutical customers. The company supports preclinical and clinical-stage programs for chemical and biological entities, with capabilities spanning drug product development, biologics drug substance development, sterile fill-finish, lyophilization, clinical trial materials, packaging, logistics, and analytical support. It operates as part of the broader Eurofins BioPharma Services network and serves both small biotech companies and larger pharmaceutical clients. Rather than developing its own therapeutic pipeline, Eurofins Amatsigroup provides integrated development, manufacturing, and testing services to advance customer programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurofins Amatsigroup.